FLGT — Fulgent Genetics Inc · catalysts, narrative & risks

Snapshot (as of 2026-10-30/31)

As of the close on October 30, 2026, FLGT traded at $20.62, down 4.89% on the day, with after-hours trading near $20.53 [4], [17]. Market capitalization was ~$567.26 million, within the 52-week range of $13.46–$31.04 [4]. This is consistent with the on-file background data (market cap ~$567.37M) [background]. Analyst consensus is a "Hold" rating with a $27.50 price target implying roughly 33.4% upside, though coverage is thin—only 2 research reports in the past 90 days [4].

Recent catalysts (roughly Aug–Oct 2026)